Examining the association between blood-based biomarkers and human post mortem neuropathology in the University of Kentucky Alzheimer's Disease Research Center autopsy cohort.
Examining the association between blood-based biomarkers and human post mortem neuropathology in the University of Kentucky Alzheimer's Disease Research Center autopsy cohort.
复制标题
在肯塔基大学阿尔茨海默病研究中心尸检队列中检查血液生物标志物与人类死后神经病理学之间的关联。
DOI:
10.1002/alz.12639
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Wilcock,DonnaM
中科院分区:
文献类型:
--
作者:
Winder,Zachary;Sudduth,TiffanyL;Anderson,Sonya;Patel,Ela;Neltner,Janna;Martin,BarbaraJ;Snyder,KatherineE;Abner,ErinL;Jicha,GregoryA;Nelson,PeterT;Wilcock,DonnaM
IntroductionClinically, detection of disease‐causing pathology associated with Alzheimer's disease (AD) and vascular contributions to cognitive impairment and dementia (VCID) is limited to magnetic resonance imaging and positron emission tomography scans, which are expensive and not widely accessible. Here, we assess angiogenic, inflammatory, and AD‐related plasma biomarkers to determine their relationships with humanpost mortemneuropathology.MethodPlasma samples were analyzed using a digital immunoassay and pathological evaluation was performed by University of Kentucky Alzheimer's Disease Research Center neuropathologists. The association of plasma markers with neuropathology was estimated via proportional odds and logistic regressions adjusted for age.ResultsIncluded cases (N = 90) showed increased tau/amyloid beta (Aβ)42 ratio, glial fibrillary acidic protein (GFAP), vascular endothelial growth factor A (VEGF‐A), and placental growth factor (PlGF) were positively associated with higher level of AD neuropathological change, while higher Aβ42/Aβ40 ratio was inversely associated. Higher PlGF, VEGF‐A, and interleukin 6 were inversely associated with chronic cerebrovascular disease, while Aβ42/Aβ40 ratio was positively associated.DiscussionOur results provide support for the continued study of plasma biomarkers as a clinical screening tool for AD and VCID pathology.